Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells

Paclitaxel has been used widely to treat breast cancer and other types of cancer. However, resistance is a major cause of failure for treatment and results in cancer progression. The present study investigated the association between paclitaxel resistance and the mesenchymal phenotype, using a model...

Descripción completa

Detalles Bibliográficos
Autores principales: Esparza-López, José, Longoria, Ossian, De La Cruz-Escobar, Eliseo Neftali, Garibay-Díaz, Julio Cesar, León-Rodríguez, Eucario, De Jesús Ibarra-Sánchez, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721864/
https://www.ncbi.nlm.nih.gov/pubmed/34992683
http://dx.doi.org/10.3892/ol.2021.13168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721864/
https://www.ncbi.nlm.nih.gov/pubmed/34992683
http://dx.doi.org/10.3892/ol.2021.13168

Ejemplares similares